Article | Outcomes | Before TX mean (SD) | After TX mean (SD) | Difference mean (SD) | Follow-up changes |
---|---|---|---|---|---|
Sugawara et al. (2002) [22] | Overbite | −2.8 (1.8) | 2.1 (0.8) | 4.9 (NA) | 1.2 (0.8) |
MP/FH | 33.1 (2.1) | 31.7 (2.4) | −1.3 (NA) | 32.2 (3.0) | |
L6-MP | 35.7 (4.1) | 33.9 (4.1) | −1.8 (NA) | 34.2 (4.4) | |
U6-PP | 24.0 (3.0) | 25.0 (2.8) | 1.0 (NA) | 25.1 (2.5) | |
LAFH | 76.1 (5.8) | 74.6 (6.0) | −1.5 (NA) | 75.2 (5.8) | |
Deguchi et al. (2011) [23] | Overbite | −4.4 (1.2) | 1.8 (1.1) | 6.2 (1.7) | 1.0 (0.9) |
MP/SN | 45.8 (6.0) | 42.2 (6.7) | −3.6 (2.1) | 43.8 (6.5) | |
U6-PP | 26.9 (3.0) | 24.6 (2.5) | −2.3 (1.3) | 25.1 (2.8) | |
L6-MP | 36.0 (2.5) | 35.2 (1.9) | −0.8 (1.3) | 37.0 (1.9) | |
LAFH | 74.7 (5.9) | 72.2 (5.1) | −2.6 (2.5) | 72.2 (5.1) | |
Buschang et al. (2011) [24] | MPA | NR | NR | −3.9 (1.8) | NA |
Akan et al. (2013) [25] | Overbite | −3.2 (1.3) | 1.5 (1.3) | 4.7 (1.3) | NA |
GoGn/SN | 45.5 (7.3) | 41.7 (7.2) | −3.7 (1.8) | ||
MP/FH | 36.3 (7.0) | 33.0 (6.9) | −3.2 (1.5) | ||
LAFH | 57.0 (4.9) | 52.8 (4.6) | −4.1 (1.7) | ||
U6-HL | 74.6 (4.4) | 71.3 (4.2) | −3.3 (1.2) | ||
L6-MP | 32.0 (3.2) | 31.2 (3.3) | −0.8 (0.8) | ||
Xun et al. (2007) [26] | Overbite | −2.2 (0.9) | 2.0 (0.3) | 4.2 (0.9) | NA |
MMA | 36.8 (4.8) | 34.3 (4.2) | −2.5 (0.9) | ||
MP/SN | 45.6 (5.8) | 43.3 (5.1) | −2.3 (0.8) | ||
LAFH | 82.2 (3.8) | 80.6 (3.4) | −1.6 (0.9) | ||
U6-PP | 26.3 (2.2) | 24.5 (2.0) | −1.8 (0.7) | ||
L6-MP | 37.4 (3.4) | 36.2 (3.3) | −1.2 (0.8) | ||
Erverdi et al. (2004) [27] | Overbite | −0.6 (2.2) | 3.1 (0.9) | 3.7 (2.4) | NA |
MMA | 36.9 (5.4) | 34.7 (4.5) | −2.2 (1.2) | ||
GoGn/SN | 46.5 (6.0) | 44.8 (6.7) | −1.7 (2.0) | ||
U6-PP | 26.4 (1.6) | 23.8 (2.7) | −2.6 (1.3) | ||
L6-MP | 32.8 (2.7) | 31.7 (3.1) | −0.1 (0.7) | ||
Erverdi et al. (2007) [28] | Overbite | −4.0 (NA) | 1.2 (NA) | 5.1 (2.0) | NA |
GoGn/SN | 42.5 (NA) | 39.5 (NA) | −3.0 (1.5) | ||
LAFH | 76.5 (NA) | 73.6 (NA) | −2.9 (1.3) | ||
U6-PP | 22.6 (NA) | 19.0 (NA) | −3.6 (1.4) | ||
Scheffler et al. (2014) [29] | Overbite | NR | NR | 2.2 (1.6) | −0.4 (1.1) |
GoGn/SN | −1.2 (1.0) | 0.0 (0.8) | |||
LAFH | −1.6 (2.2) | −0.3 (1.4) | |||
U6-PP | −2.3 (1.4) | 0.5 (1.2) | |||
L6-GoGn | 0.6 (1.6) | −0.3 (1.3) | |||
Foot et al. (2014) [30] | Overbite | −2.2 (1.7) | 0.8 (1.1) | 3.0 (1.5) | NA |
MMA | 31.8 (3.8) | 30.7 (4.3) | −1.0 (1.3) | ||
MP/SN | 36.1 (4.9) | 34.9 (5.3) | −1.2 (1.3) | ||
MP/FH | 27.8 (3.5) | 26.9 (3.6) | −0.9 (1.2) | ||
LAFH | 61.8 (4.3) | 60.9 (4.6) | −0.9 (1.1) | ||
U6-PP | 20.6 (2.3) | 17.7 (2.4) | −2.9 (0.8) | ||
L6-MP | 27.9 (2.9) | 28.0 (2.9) | 0.1 (0.4) | ||
Kuroda et al. (2007) [10] | Overbite | −5.2 (1.8) | 1.5 (0.6) | 6.8 (1.7) | NA |
MP/FH | 38.8 (6.4) | 35.5 (6.9) | −3.3 (1.5) | ||
LAFH | 78.6 (5.5) | 75.0 (4.7) | −3.6 (1.8) | ||
U6-PP | 28.7 (2.8) | 26.4 (2.4) | −2.3 (2.0) | ||
L6-MP | 38.0 (1.8) | 36.7 (1.6) | −1.3 (1.2) | ||
Hart et al. (2015) [32] | Overbite | −3.0 (1.9) | 0.8 (1.4) | 3.8 (0.9) | NA |
MP/FH | 32.4 (6.3) | 31.3 (6.9) | −1.1 (0.09) | ||
LAFH | 73.3 (7.4) | 71.8 (7.1) | −1.5 (0.03) | ||
U6-PP | 23.7 (3.3) | 21.4 (3.2) | −2.3 (0.06) | ||
U6-BaH | 27.4 (3.7) | 25.7 (3.7) | −1.7 (0.10) | ||
L6-MP | 30.4 (3.1) | 31.5 (3.3) | 1.1 (0.05) | ||
Lee and Park. (2008) [31] | Overbite | −3.7 (1.7) | 1.7 (0.7) | 5.4 (1.8) | 0.7 (0.7) |
MeGo/SN | 44.9 (3.9) | 42.9 (4.5) | −2.0 (1.7) | 43.0 (4.8) | |
MP/FH | 37.9 (3.1) | 35.0 (3.6) | −2.8 (2.0) | 35.9 (3.8) | |
AFH | 133.4 (5.4) | 130.8 (5.7) | −2.6 (1.9) | 131.1 (5.4) | |
U6-PP | 26.7 (1.2) | 24.5 (1.7) | −2.2 (1.7) | 24.7 (1.6) |